(NASDAQ: BLFS) Biolife Solutions's forecast annual revenue growth rate of 5.1% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.57%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Biolife Solutions's revenue in 2024 is $143,271,000.On average, 3 Wall Street analysts forecast BLFS's revenue for 2024 to be $5,303,089,800, with the lowest BLFS revenue forecast at $4,416,750,000, and the highest BLFS revenue forecast at $6,650,040,000.
In 2025, BLFS is forecast to generate $6,419,010,000 in revenue, with the lowest revenue forecast at $5,073,600,000 and the highest revenue forecast at $7,841,430,000.